Search

everythinglearnresearchcommunity

for

Search:↓

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Personality traits and anxiety affect hair loss patients' quality of life.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.